Skip to main content

Table 4 Suggested screening strategies based on cost-effectiveness analysis, stratified by age and BMI group

From: Cost-effectiveness analysis for HbA1c test intervals to screen patients with type 2 diabetes based on risk stratification

 

Age group

30–44

45–59

60–74

BMI group

Underweight

10-year

10-year

3-year

Normal

6-year

6-year

3-year

Overweight

4-year

3-year

3-year

Obese

3-year

3-year

3-year